Cargando…

Bone Marrow Immune Microenvironment in Myelodysplastic Syndromes

SIMPLE SUMMARY: The bone marrow (BM) microenvironment regulates normal hematopoiesis and exerts variable activity in various inflammatory, toxic, autoimmune, or neoplastic diseases and conditions. Most importantly, it has a major role in the pathogenesis of BM failure syndromes and particularly of m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kouroukli, Olga, Symeonidis, Argiris, Foukas, Periklis, Maragkou, Myrto-Kalliopi, Kourea, Eleni P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688609/ https://www.ncbi.nlm.nih.gov/pubmed/36428749 http://dx.doi.org/10.3390/cancers14225656

Ejemplares similares

Nature or Nurture? Role of the Bone Marrow Microenvironment in the Genesis and Maintenance of Myelodysplastic Syndromes
por: Mian, Syed A., et al.
Publicado: (2021)

Contingent Synergistic Interactions between Non-Coding RNAs and DNA-Modifying Enzymes in Myelodysplastic Syndromes
por: Symeonidis, Argiris, et al.
Publicado: (2022)

Myelodysplastic Syndromes with Bone Marrow Fibrosis: An Update
por: Jain, Akriti G., et al.
Publicado: (2022)

Increased Expression of Interferon Signaling Genes in the Bone Marrow Microenvironment of Myelodysplastic Syndromes
por: Kim, Miyoung, et al.
Publicado: (2015)

Bone marrow niches in myelodysplastic syndromes
por: Tosato, Giovanna, et al.
Publicado: (2021)

PB2206: FULL SPECTRAL FLOW CYTOMETRY ANALYSIS OF THE BONE MARROW IMMUNE MICROENVIRONMENT IN PATIENTS WITH MYELODYSPLASTIC SYNDROME
por: chen, M., et al.
Publicado: (2022)

P704: ABERRANT IMMUNE MICROENVIRONMENT IN BONE MARROW OF MYELODYSPLASTIC SYNDROME PATIENTS DRIVES A SUPPRESSIVE PHENOTYPE
por: Rai, Richa, et al.
Publicado: (2023)

PB1917: PROGNOSTIC AND PREDICTIVE SIGNIFICANCE OF ELEMENTS OF THE ADAPTIVE IMMUNITY IN THE MICROENVIRONMENT OF MYELODYSPLASTIC SYNDROMES TREATED WITH 5-AZACITIDINE
por: Tsakiraki, Z., et al.
Publicado: (2022)

Common cardiovascular biomarkers can independently predict outcome of patients with Myelodysplastic syndromes
por: Mitroulis, Ioannis, et al.
Publicado: (2023)

Analysis of Immune-Cell Distribution of Bone Marrow in Patients with Myelodysplastic Syndrome
por: Lin, Chun-Liang, et al.
Publicado: (2023)

Practical Guide to Bone Marrow Sampling for Suspected Myelodysplastic Syndromes
por: Ridgeway, Jean A., et al.
Publicado: (2017)

The incidence of myelodysplastic syndromes in Western Greece is increasing
por: Avgerinou, Christina, et al.
Publicado: (2013)

Immune checkpoints bone marrow expression as the predictor of clinical outcome in myelodysplastic syndrome
por: Tcvetkov, Nikolai, et al.
Publicado: (2020)

Allogeneic Hematopoietic Stem Cell Transplantation for Mixed or Overlap Myelodysplastic/Myeloproliferative Disorders
por: Symeonidis, Argiris, et al.
Publicado: (2022)

Cytokine expression patterns and mesenchymal stem cell karyotypes from the bone marrow microenvironment of patients with myelodysplastic syndromes
por: Xiong, H., et al.
Publicado: (2015)

Hypoplastic myelodysplastic syndrome and acquired aplastic anemia: Immune-mediated bone marrow failure syndromes (Review)
por: Votavova, Hana, et al.
Publicado: (2021)

Human bocavirus is not detectable in bone marrow from patients with myelodysplastic syndromes
por: Schildgen, Verena, et al.
Publicado: (2011)

Immune Mechanisms in Myelodysplastic Syndrome
por: Glenthøj, Andreas, et al.
Publicado: (2016)

Dysfunctional bone marrow endothelial progenitor cells are involved in patients with myelodysplastic syndromes
por: Xing, Tong, et al.
Publicado: (2022)

When Ring Sideroblasts on Bone Marrow Smears Are Inconsistent with the Diagnosis of Myelodysplastic Neoplasms
por: Girard, Sandrine, et al.
Publicado: (2022)

The growth of myelodysplastic bone marrow in long-term cultures.
por: Borbenyi, Z., et al.
Publicado: (1987)

Bone Marrow Microenvironment and Tumor Progression
por: Chantrain, Christophe F., et al.
Publicado: (2008)

The microenvironment in myelodysplastic syndromes: From concept to therapeutic target
por: Raaijmakers, Marc H.G.P.
Publicado: (2018)

Refinement of prognosis and the effect of azacitidine in intermediate-risk myelodysplastic syndromes
por: Liapis, Konstantinos, et al.
Publicado: (2021)

Challenges for Immunotherapy in Multiple Myeloma: Bone Marrow Microenvironment-Mediated Immune Suppression and Immune Resistance
por: Holthof, Lisa C., et al.
Publicado: (2020)

Fidelity of peripheral blood for monitoring genomics and tumor immune‐microenvironment in myelodysplastic syndromes
por: Lee, Sung‐Eun, et al.
Publicado: (2020)

Bone marrow fibrosis in myelodysplastic syndromes: a prospective evaluation including mutational analysis
por: Ramos, Fernando, et al.
Publicado: (2016)

Isolation, culture, and immunophenotypic analysis of bone marrow HSPCs from patients with myelodysplastic syndromes
por: Ganan-Gomez, Irene, et al.
Publicado: (2022)

Deep learning application of the discrimination of bone marrow aspiration cells in patients with myelodysplastic syndromes
por: Lee, Nuri, et al.
Publicado: (2022)

The bone marrow stroma in human myelodysplastic syndrome reveals alterations that regulate disease progression
por: Kfoury, Youmna S., et al.
Publicado: (2023)

Real world data on the prognostic significance of monocytopenia in myelodysplastic syndrome
por: Diamantopoulos, Panagiotis T., et al.
Publicado: (2022)

Myelodysplastic hematopoiesis mimicking the bone marrow in a mediastinal myelolipoma
por: Takano, Hina, et al.
Publicado: (2017)

Bone Marrow Microenvironment in Multiple Myeloma Progression
por: Manier, S., et al.
Publicado: (2012)

PB2028: ACQUIRED Α-THALASSEMIA IN A PATIENT WITH HIGH-RISK MYELODYSPLASTIC SYNDROME AND BONE MARROW FIBROSIS: CASE REPORT AND LITERATURE REVIEW
por: Chissan, Sofia, et al.
Publicado: (2023)

Risk factors for cardiovascular disease mortality in patients with myelodysplastic syndromes: A nationwide, registry‐based cohort study
por: Liapis, Konstantinos, et al.
Publicado: (2020)

Bone marrow microenvironment: The guardian of leukemia stem cells
por: Houshmand, Mohammad, et al.
Publicado: (2019)

Wnt Signaling in Leukemia and Its Bone Marrow Microenvironment
por: Ruan, Yongsheng, et al.
Publicado: (2020)

The Bone Marrow Microenvironment in B-Cell Development and Malignancy
por: Hughes, Anastasia M., et al.
Publicado: (2022)

Circular RNAs Activity in the Leukemic Bone Marrow Microenvironment
por: Liccardo, Francesca, et al.
Publicado: (2022)

Treating Multiple Myeloma in the Context of the Bone Marrow Microenvironment
por: Ho, Matthew, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j2sc07e45amrajkc83ghu6dt0j